Related by context. All words. (Click for frequent words.) 73 BRIM3 70 Randomized Phase 69 Clinical Trial Results 69 ongoing Phase 1b 69 Pivotal Phase III 69 midstage clinical 69 Initiates Phase III 68 Vicriviroc 68 #th Annual Interscience 68 fidaxomicin Phase 3 68 Nasdaq DVAX 68 AVERROES 68 Investigational Compound 68 Phase Ib study 68 Phase 1a clinical 68 phase IIb 67 evaluating tivozanib 67 interferon gamma 1b 67 SABCS 67 Completes Patient Enrollment 67 BRIM2 67 teriflunomide 67 dose escalation clinical 67 AVADO 67 SAR# [004] 67 Phase III placebo controlled 67 virus HCV protease inhibitor 67 #nd EORTC NCI 67 Initiated Phase 67 NASDAQ CYTK announced 67 Phase IIIb clinical 67 elotuzumab 67 multicenter placebo controlled 67 Tezampanel 66 sNDA submission 66 NVA# 66 Prostate AdenoCarcinoma Treatment 66 phase III isavuconazole 66 Optimer Pharmaceuticals Inc 66 Presents Preclinical 66 REG1 Anticoagulation System 66 Phase Ib clinical 66 SUTENT ® 66 CLARITY study 66 Initiate Phase 66 phase IIa 66 BiTE R 66 Late Breaker 66 JAK Inhibitor 66 Combination REOLYSIN R 66 phase IIb study 66 TASKi2 66 Sprycel dasatinib 66 Nasdaq REGN 66 Randomized Phase II 66 AVOREN 66 Phase Ib II 66 MERLIN TIMI 66 ENDEAVOR III 66 Ambrisentan 66 R roscovitine 66 trastuzumab DM1 66 Safinamide 66 Romiplostim 66 Androxal TM 66 Aflibercept 65 PreCISe 65 evaluating mipomersen 65 Phase III AFFIRM 65 Intervention Effectiveness 65 Therapeutic Competitors companiesandmarkets.com adEgemonye 65 HCV SPRINT 65 Femara letrozole 65 Phase III ALLEGRO 65 phase IIb clinical 65 ExTRACT TIMI 65 EXPLORE Xa 65 RECORD1 65 EORTC NCI AACR 65 Meets Primary Endpoint 65 Presents Preclinical Data 65 azilsartan medoxomil 65 Brentuximab Vedotin SGN 65 Randomized Double blind 65 multicenter Phase II 65 Phase 2a Study 65 Presents Positive 65 Glufosfamide 65 adecatumumab MT# 65 SUCCEED trial 65 Xelox 65 Sutent sunitinib malate 65 PROSTVAC TM 65 evaluating satraplatin 65 DASISION 65 severe hypercholesterolemia 65 Initiates Phase II 65 Elagolix 65 phase IIIb 65 NASDAQ CXSP announced 65 ALN VSP Phase 65 NASDAQ ARRY 65 JAK inhibitor 65 Nasdaq IDRA today 65 Nasdaq IMMU 65 Corlux 65 Breaking Clinical Trial 65 compound INCB# 65 DEB# 65 Zenvia Phase III 65 ASCO GI 65 ASTEROID 65 Phase III ADT 65 Zarnestra 65 PEG SN# 64 MIVI III 64 Auxilium Pharma 64 Telbivudine 64 PFE PFE 64 orally inhaled migraine 64 Avanir Pharmaceuticals Inc 64 trastuzumab DM1 T DM1 64 ASH Annual Meeting 64 Dasatinib 64 Inc. Nasdaq BIOD 64 Phase #/#a 64 Muraglitazar 64 investigational humanized monoclonal antibody 64 Novel Oral 64 fidaxomicin Phase 64 initiated Phase Ib 64 FOLOTYN ® 64 Begins Dosing 64 axitinib 64 LAF# 64 Phase III Clinical Trial 64 ABCSG 64 ToGA 64 Impax Laboratories Inc 64 ziprasidone Geodon 64 CAMMS# 64 SPIRIT FIRST 64 Sym# 64 NASDAQ REGN 64 trastuzumab emtansine T DM1 64 Pivotal Phase 64 Phase IIb III 64 IG HCR ;) CO 64 SPIRIT IV 64 bicifadine 64 Xcytrin R 64 Xoma Ltd 64 SmPC 64 PROVENGE sipuleucel T 64 Oral Fingolimod 64 AACR NCI EORTC 64 phase IIa clinical 64 BRILINTA 64 randomized controlled multicenter 64 Gastrointestinal Cancers Symposium 64 ADVANCE PD 64 AACR San Antonio 64 Clinical Oncology Annual Meeting 64 LUX Lung 64 Initiates Enrollment 64 Nasdaq IDRA 64 Study Evaluating 64 Completes Enrollment 64 Phase 2b Clinical Trial 64 candidate CRLX# 64 NASDAQ ISTA 64 ROCKET AF 64 Dapagliflozin 64 BRAF inhibitor 64 phase IIb trial 64 non nucleoside inhibitor 64 fostamatinib 64 TransVax 64 Rigel R# 64 BOLDER II 64 Nasdaq OSIP 64 Regeneron Pharma 64 Initiates Clinical 64 TRANSFORMS 64 Vectibix panitumumab 64 MEND CABG 63 PERSEUS 63 Romidepsin 63 Inc. Nasdaq IMGN 63 Vitaxin 63 Phase Ib IIa 63 Nasdaq OPTR 63 multicenter multinational 63 phase IIb III 63 Plicera 63 PRE SURGE 63 Potent Antiviral Activity 63 Severe Sepsis 63 preclinical pharmacokinetic 63 TBC# 63 Pivotal Clinical Trial 63 PROTECT AF 63 cetuximab Erbitux 63 alvespimycin 63 NV1FGF 63 Nexavar sorafenib 63 octreotide acetate 63 Alnylam Nasdaq ALNY 63 Phase IIb Trial 63 Interferon beta 1b 63 IL# PE#QQR 63 Selective Cardiac Myosin 63 RGB # 63 randomized controlled Phase 63 Aliskiren 63 RANK Ligand inhibitor 63 Vernakalant 63 neratinib 63 phase Ib 63 Pivotal Study 63 MBRX 63 Phase IIIb 63 oral methylnaltrexone 63 Phase 2a Clinical Trial 63 AACR symposium 63 Sibutramine Cardiovascular Outcomes 63 GENASIS 63 Clinical Trials Update 63 EURIDIS 63 YONDELIS 63 Humira adalimumab 63 huC# DM4 63 LEVADEX ™ 63 antibody blinatumomab MT#/MEDI-# 63 Pazopanib 63 HCV NS5B polymerase 63 #th Interscience Conference 63 Solorel TM 63 mertansine 63 docetaxel Taxotere R 63 PRIMO CABG 63 AASLD Meeting 63 TG MV 63 Randomized Double Blind Placebo 63 LymphoStat B TM 63 lumiliximab 63 randomized discontinuation trial 63 Tasigna nilotinib 63 Phase III psoriasis 63 Seattle Genetics SGEN 63 Breaking Clinical Trials 63 Multiple Ascending Dose 63 BCIRG 63 Celebrex celecoxib 63 Trastuzumab DM1 63 bazedoxifene conjugated estrogens 63 Achieves Primary Endpoint 63 ASCO abstract 63 Society CTOS 63 AIM HIGH 63 cediranib 63 Randomized Double Blind 63 Trandolapril 63 HuMax EGFr 63 methylnaltrexone 63 CATIE AD 63 TASKi3 63 multicenter Phase III 63 sorafenib Nexavar 63 Therapeutics TCT scientific 63 NASDAQ AVNR 63 ocrelizumab 63 PRN FDA Approves 63 Submits NDA 62 TRX1 62 PROVENGE ® 62 Immunomedics Inc 62 thalidomide Thalomid 62 KRN# 62 Nasdaq CYCC Nasdaq CYCCP 62 ENDEAVOR IV 62 preclinical efficacy 62 docetaxel Taxotere ® 62 randomized Phase III 62 Cimzia ® certolizumab pegol 62 pivotal bioequivalence 62 IMPACT DCM 62 zoledronic acid Reclast 62 assessing T DM1 62 including eniluracil ADH 62 NO# [002] 62 Avanafil 62 XL# SAR# 62 Completes Dosing 62 Nasdaq ICOS 62 Temsirolimus 62 Nasdaq PGNX 62 selective estrogen receptor modulator 62 Sorafenib HCC Assessment 62 CLARITY TIMI 62 TRACON Pharmaceuticals 62 sipuleucel T 62 oral ridaforolimus 62 tenofovir emtricitabine 62 Nasdaq SNSS 62 Inc FRX FRX 62 Drug Fails 62 IND Filing 62 ANCHOR trial 62 Placebo Controlled Trial 62 ORENCIA ® 62 atrasentan 62 ENESTnd 62 GSK# [002] 62 eltrombopag 62 evaluating satraplatin plus 62 Inc. NASDAQ SGEN 62 Carfilzomib 62 Phase III Trial 62 Incyte Corp 62 Pivotal Trial 62 crizotinib PF # 62 Urocortin 2 62 brivaracetam 62 CUSTOM III 62 Hsp# Inhibitor 62 multicenter randomized placebo controlled 62 ASCO Annual Meeting 62 NASDAQ ABII 62 BIIB BIIB 62 placebo controlled Phase 62 AEGR 62 fosbretabulin 62 CROI 62 Golimumab 62 Tibotec BVBA 62 Inc. Nasdaq SEPR 62 Amrubicin 62 Ocrelizumab 62 CCX# 62 Actimmune ® 62 BLOOM DM 62 non nucleoside HCV 62 Tykerb lapatinib 62 panitumumab Vectibix 62 APEX PD 62 Active Biotech NASDAQ OMX 62 HCV RESPOND 2 62 Eszopiclone 62 evaluating Actimmune 62 MAGE A3 ASCI 62 Inc. Nasdaq MITI 62 Parathyroid Hormone 62 Adentri 62 Nasdaq PGNX today 62 Nasdaq GNTA 62 randomized Phase IIb 62 oral prodrug 62 Preclinical Study 62 Phase III ThermoDox 62 Dalbavancin 62 landmark ATHENA 62 HCV protease inhibitor 62 phase 2a 62 ACTIVE W 62 Randomized Phase III 62 Mipomersen 62 Boceprevir 62 Zegerid OTC 62 Cetrorelix 62 Phase IIB 62 selective androgen receptor modulator 62 hoFH 62 Kinase Inhibitor 62 metaglidasen 62 oxymorphone ER 62 ICAAC IDSA 62 USpella 62 enzastaurin 62 NSABP C 62 MKC# MT 62 Nasdaq NYMX 62 Febuxostat 62 Double Blind Placebo 62 Patient Enrollment 62 etanercept Enbrel 62 Phase 2a Trial 62 GILD GILD 62 ZOLINZA 62 Phase IIA 62 radezolid 62 placebo controlled Phase III 62 Nasdaq ACHN 62 Nasdaq HALO 62 GetGoal Phase III 62 atazanavir sulfate 62 Mg Usa 62 Hormone Refractory Prostate Cancer 62 Tovaxin Phase IIb 62 NASDAQ PGNX 62 Hedgehog Pathway Inhibitor 62 memantine HCl 62 REMINYL ® 62 PTK ZK 62 PSMA ADC 62 Product Monograph 62 NASDAQ TARG 62 novel VDA molecule 62 Presents Positive Preclinical 62 NASDAQ IDRA 62 Dose Escalation 62 investigational protease inhibitor 62 Sanofi aventis EURONEXT SAN 62 midstage trials 62 QNEXA 61 EDEMA3 61 Naproxcinod 61 Platelet Inhibition 61 CLL8 61 Cloretazine ® 61 ONGLYZA ™ 61 EVEREST II 61 Genasense ® oblimersen 61 NASDAQ CLDX 61 ritonavir boosted danoprevir 61 SPRYCEL ® 61 CONBRIZA 61 Zybrestat 61 arzoxifene 61 Pooled Analysis 61 Phase III Clinical Trials 61 Relapsed Multiple Myeloma 61 Glucophage XR 61 EXPAREL ™ 61 Pirfenidone 61 combines bupropion 61 NASDAQ DYAX 61 European CanCer Organisation ECCO 61 Nasdaq IMGN 61 Inc. Nasdaq MLNM 61 nucleotide analogue 61 Nordic ACTI 61 R#/MEM 61 multicenter randomized controlled 61 Matrix Phase 2b 61 riociguat 61 methylnaltrexone bromide 61 RIO Lipids 61 Phase 2b Study 61 Therapeutic Competitors 61 Inc. NASDAQ HEPH 61 Investigational Oral 61 Controlled Trial 61 Progenics Pharmaceuticals 61 placebo controlled clinical 61 multicenter Phase 61 Biomarker Study 61 ocular formulation 61 Multicenter Phase 61 ACCORD Lipid 61 Randomized Clinical Trial 61 Civacir 61 CCR5 mAb 61 PSN# [002] 61 NASDAQ ARIA 61 ARBITER 6 61 NDA Submission 61 Deforolimus 61 TAXUS ATLAS 61 Glatiramer Acetate 61 GOUT 61 galiximab 61 Announces Poster Presentations 61 Blind Placebo Controlled Trial 61 PHX# 61 Traficet EN 61 Cinquil 61 cannabinor 61 multicenter randomized Phase 61 UPLYSO 61 generation antisense inhibitor 61 Telik logo TELINTRA 61 number NCT# ClinicalTrials.gov 61 Sunesis Pharma 61 PROactive Study 61 Neupro R 61 CARE HF 61 confirmatory clinical 61 Ereska 61 MEK Inhibitor 61 thorough QT 61 Valtropin 61 NasdaqGM NTEC today 61 PRNewswire FirstCall Cytokinetics Incorporated 61 Pafuramidine 61 HDAC Inhibitor 61 PEGINTRON TM 61 Reports Preclinical Data 61 Eluting Stent 61 Velcade bortezomib 61 Inc. Nasdaq MDVN 61 Submits Response 61 viral kinetic 61 Preclinical Data 61 NSABP B 61 Aryplase 61 Canaccord Adams Hepatitis C 61 Clinical Trial Data 61 torezolid phosphate 61 cetuximab Erbitux R 61 investigational antiplatelet agent 61 metastatic castration resistant 61 Efficacy Results 61 Clinical Antipsychotic Trials 61 TLK# 61 ribavirin USP 61 STRIDE PD 61 Belimumab 61 Arranon 61 Advanced Neuroendocrine Tumors 61 baminercept 61 Tanespimycin 61 Inc Therapeutic Competitors 61 Hodgkin lymphoma HL 61 Rebif ® 61 Tesetaxel 61 Systemic Delivery 61 ONTARGET 61 seliciclib CYC# 61 Phase 2a clinical 61 registrational Phase 61 R lenalidomide 61 Amex ANX 61 First Patient Enrolled 61 forodesine 61 Phase IIa clinical 61 Nasdaq ALXN 61 Saxagliptin 61 oral rivaroxaban 61 ILLUMINATE 61 Drug Candidate 61 tarenflurbil 61 Cholesterol Lowering Drug 61 prospective multicenter randomized 61 Bazedoxifene 61 multicenter phase 61 controlled multicenter Phase 61 abstracts summarizing 61 oral JAK1 61 Silodosin 61 histone deacetylase HDAC inhibitor 61 sunitinib Sutent 61 TORISEL TM 61 ITAX 61 PLAVIX ® 61 CIP TRAMADOL ER 61 CALGB # [002] 61 sunitinib malate 61 ORENCIA R 61 TACI Ig 61 oral salmon calcitonin 61 Initiates Phase 2b 61 ThermoDox ® clinical 61 Genta Incorporated OTCBB GETA 61 II Clinical Trial 61 Auxilium Pharmaceuticals Inc 61 brivanib 61 albiglutide 61 Active Ulcerative Colitis 61 ECASS 61 DU #b 61 INSPIRE Trial Phase III 61 AZILECT R 61 Chicago Multidisciplinary Symposium 61 NYSE Amex PTN 61 Commences Phase 61 NASDAQ ALTH 61 Inc. NASDAQ SNUS 61 vascular disrupting agent 61 OvaRex ® MAb 61 RoACTEMRA 61 MGd 61 PF # [002] 61 EASL 61 Achillion Pharmaceuticals Inc 61 R rosiglitazone maleate 61 Motesanib 60 Initiates Clinical Trial 60 mapatumumab 60 Nasdaq INCY 60 Dacogen injection 60 Inflammatory Arthritis 60 pioglitazone hydrochloride 60 multi kinase inhibitor 60 nalbuphine ER 60 Nasdaq NBIX 60 DIRECT Trial 60 please visit http:/www.atherogenics.com 60 Edge STudy 60 NASDAQ OPTR 60 Zemplar Capsules 60 Contrave# 60 Silenor NDA 60 ASCO Gastrointestinal Cancers Symposium 60 Diabetologia 60 RhuDex 60 tanespimycin 60 Phase #b/#a trial 60 Namenda Memantine HCl 60 desvenlafaxine succinate 60 ACOMPLIA R 60 CHAMPION PCI 60 RELOVAIR ™ 60 Progenics Pharmaceuticals Inc 60 Mycamine 60 Vildagliptin 60 Vidaza R 60 valsartan Diovan 60 Valsartan 60 RIO Diabetes 60 iniparib 60 Nasdaq NPSP 60 Idenix Pharmaceuticals Inc 60 PharmaVitae Profile 60 Second Pivotal Phase 60 LymphoStat B belimumab 60 Phase III Pivotal 60 Phase III VISTA 60 Targanta Therapeutics Corporation 60 aripiprazole Abilify 60 novel histone deacetylase 60 AMPAKINE CX# 60 deforolimus 60 Inc. NASDAQ SUPG 60 Phase IIb Clinical Trial 60 NASDAQ EMIS 60 IMPACT IMmunotherapy 60 Long Term Efficacy 60 NASDAQ ONXX 60 antidepressants fluoxetine 60 EGS# 60 Therapeutic Competitors Companies 60 cathepsin K inhibitor 60 Nasdaq NRGN 60 sitaxsentan 60 Sapacitabine 60 PCK# 60 pan HDAC inhibitor 60 Inc. NASDAQ BPAX 60 INCB# [001] 60 Unit Dose Budesonide 60 NASDAQ NPSP 60 pravastatin Pravachol 60 delafloxacin 60 Gilead Viread 60 aclidinium bromide 60 Immunogenicity 60 Nasdaq MAPP 60 Submits Biologics License Application 60 Inc. Nasdaq KERX 60 inhalation aerosol 60 Randomized Study 60 Guanilib 60 Personalized Immunotherapy 60 NASDAQ SNTA 60 Denufosol 60 Diovan Exforge Tekturna Zelnorm 60 Product Characteristics 60 Nasdaq ENZN 60 CombAT 60 SYMMETRY trial 60 ritonavir boosted 60 pertuzumab 60 RAD# everolimus 60 ACAPODENE 60 SAR# [002] 60 Phase 2b kidney transplant 60 Shows Efficacy 60 ® pioglitazone HCl 60 tramiprosate Alzhemed TM 60 Arzerra TM 60 Vfend 60 Cites Positive 60 Keppra XR 60 Phase IIb randomized 60 Intervention Effectiveness CATIE 60 Antiviral Activity 60 HCV Protease Inhibitor 60 delivery polymer matrix 60 TMC# C# 60 Dose Ranging 60 AACR #st Annual Meeting 60 Novartis VIRT X 60 HFA MDI 60 Ranolazine 60 INS# [001] 60 EDEMA4 60 RE LY ® 60 Alternext ALEHT 60 PREOS R 60 ganetespib 60 blood thinner Xarelto 60 CIMZIA TM certolizumab pegol 60 Inc. NASDAQ ZLCS 60 Migraine Drug 60 HORIZONS AMI 60 PDX pralatrexate 60 Dealmaking Profile 60 eprotirome 60 dimebon latrepirdine 60 candesartan cilexetil 60 Vitro Activity 60 Demonstrates Positive 60 Kuvan sapropterin dihydrochloride 60 Phase 2b Trial 60 Cardiotoxicity 60 adalimumab Humira 60 Cleviprex TM clevidipine 60 Nasdaq MITI 60 CTRC AACR San Antonio 60 PrevOnco 60 blinded randomized placebo controlled 60 Hematological Malignancies 60 Betaferon ® 60 AMEX DDD 60 OTC BB EMIS 60 lexidronam injection 60 nitric oxide donating prostaglandin 60 Phase 2a trial 60 RAPTIVA 60 Molecular Cancer 60 Nasdaq KOSN 60 CORDAPTIVE 60 Betaferon R 60 Nasdaq DEPO 60 Aurograb 60 LENALIDOMIDE 60 Topline Results 60 EURONEXT SAN 60 Nasdaq ONXX today 60 initiated Phase 1b 60 Rivaroxaban 60 Ozarelix 60 Corp. CELG 60 Tipranavir 60 BR.# 60 Degarelix 60 SPL# Gel vaginal microbicide 60 Lexapro Effexor Serzone 60 Tekturna HCT 60 AstraZeneca AZN.L 行情 60 ARCOXIA 60 TWYNSTA ® 60 Nasdaq PPHM 60 CRTX 60 Neuvenge 60 Annamycin 60 Co MRK MRK 60 EORTC NCI AACR Symposium 60 Nasdaq QGEN 60 pregabalin Lyrica 60 subanalysis 60 Prospective Multicenter 60 standard chemotherapy regimen 60 AAG geldanamycin analog 60 Zoloft sertraline 60 Kamada AAT 60 bepotastine besilate nasal spray 60 atacicept 60 DDP# 60 entitled Synergistic 60 XL# XL# XL# 60 Connective Tissue Oncology 60 ralfinamide 60 Inc. Nasdaq ZGEN 60 Cadence Pharmaceuticals Inc 60 angiogenesis inhibitor 60 evaluating Vectibix 60 Bristol Myers Squibb Pravachol 60 Amoxicillin PULSYS Phase III 60 Inc. Nasdaq OXGN 60 Targretin capsules 60 Inc. www.micromet inc.com 60 immunotherapeutic agent 60 blood thinner prasugrel 60 fluvastatin 60 telomerase inhibitor drug 60 RE LY 60 Ophena TM 60 MEK inhibitor 60 GlaxoSmithKline MedImmune 60 Omnitarg 60 Iloperidone 60 darapladib 60 LymphoStat B 60 tasocitinib 60 miconazole Lauriad ® 60 Phase 1b clinical trials 60 ponatinib 60 Ropinirole 60 Fesoterodine 60 ALN HPN 60 telcagepant 60 phase Ib clinical 60 adipiplon 60 QLT# 60 Lung Cancer Drug 60 Nasdaq INCY announced 60 dacetuzumab collaboration 60 proteasome inhibitor 60 MERIT ES 60 Kosan Biosciences Incorporated 60 REVIVE TA 60 AMD# [002] 60 Immunomedics Announces 60 Risperidone Oral Solution 60 Oral Insulin Capsule 60 lintuzumab SGN 60 Refractory Angina 60 PDUFA Date 60 vismodegib 60 Optimer Pharma 60 GAMMAGARD 60 BiTE antibody MT# 60 APPRAISE 60 Patient Enrolment 60 NCCTG N# 60 Marketing Authorisation Application 60 reduce serum phosphate 60 KB# [002] 60 NasdaqGM SPPI 60 Azedra 60 CUSTOM II 60 Reverset 60 Inc AMGN AMGN 60 Nasdaq PARD 60 Nasdaq IDIX 60 Safety Tolerability 60 SinuNase ™ 60 NASDAQ OMER 60 Phase #b/#a 60 CERVARIX 60 pomalidomide 60 ChronVac C 60 serotonin norepinephrine reuptake inhibitor 60 Annual Transcatheter Cardiovascular 60 Pemetrexed 60 Cipralex ® 60 Phase 1b trial 60 Tocilizumab 60 Keryx Biopharma 59 Prozac fluoxetine 59 Randomised 59 ALGRX 59 #I TM# 59 Targretin 59 Nasdaq NPSP announced 59 Paliperidone Palmitate 59 Phase IIa trial 59 Arthritis Drug 59 NASDAQ NYMX 59 pharmacokinetic PK 59 Zenvia ™ 59 Nasdaq ALKS 59 NASDAQ VRTX 59 relapsed MM 59 LibiGel ® 59 oral FTY# 59 Methylnaltrexone 59 Investigational Drug 59 Eloxatin ® 59 Tarceva TM 59 Pimavanserin 59 Aurexis 59 posaconazole 59 Nasdaq VVUS 59 Demonstrates Significant 59 icatibant 59 R sorafenib tablets 59 multicenter prospective 59 volociximab 59 Inc. Nasdaq NEOL 59 Transcept Pharmaceuticals 59 Eniluracil 59 hepatitis B vaccine Heplisav 59 selective S#P# receptor agonist 59 desvenlafaxine 59 NEUVENGE 59 treatment naive genotype 59 Phase lll 59 MRK Quote Chart 59 pemetrexed Alimta 59 Biodel Inc 59 ON #.Na 59 humanized interleukin 6 59 NASDAQ ACOR 59 comparing alemtuzumab 59 ZOMIG R 59 pharmacokinetic PK study 59 novel synthetic PEGylated 59 Atelvia 59 clazosentan 59 Taxotere chemotherapy 59 L BLP# 59 CYT# potent vascular disrupting 59 REYATAZ R 59 acyclovir Lauriad R 59 Nasdaq RDEA 59 VA# [002] 59 Fondaparinux 59 PDE4 inhibitor 59 Nasdaq EMIS 59 Aganocide ® 59 PRNewswire FirstCall Sanofi aventis 59 Levetiracetam 59 liposomal formulation 59 liposome injection 59 dextromethorphan quinidine 59 tocilizumab 59 Nymox Pharmaceutical 59 refractory chronic lymphocytic 59 Xibrom TM 59 League Against Rheumatism 59 rNAPc2 59 NGSX 59 Femring ® 59 Pharmacokinetic 59 Vertex hepatitis C 59 Calcium Acetate 59 relapsed MCL 59 FDA Approvable Letter 59 multicentre randomized 59 annual Transcatheter Cardiovascular 59 HORIZONS AMI trial 59 Teriflunomide 59 Mg Uk 59 Rosuvastatin 59 Roche Boniva 59 atorvastatin Lipitor 59 DCCR 59 Proellex TM 59 Oncology Compounds 59 RE LY trial 59 tolevamer 59 experimental hepatitis C 59 Protease Inhibitor 59 AVRX 59 Acute Ischemic Stroke 59 CERVARIX R 59 Tolvaptan 59 Dendritic Cells 59 MKC# MKC# PP 59 JAK2 Inhibitor 59 Inc. Nasdaq CYCC 59 Phase III Trials 59 Tesamorelin 59 buccal spray 59 Incyte Corporation 59 UEGW 59 zafirlukast 59 CRLX# 59 vidofludimus 59 dose escalation trial 59 Phase 2b monotherapy 59 PERSEUS clinical program 59 Telithromycin 59 Nasdaq ACAD 59 GATTEX TM 59 Phase #b/#a clinical 59 Laquinimod 59 TRITON TIMI 59 Phase IIB clinical 59 budesonide foam 59 Nasdaq ONXX 59 SCH # 59 NASDAQ PCYC 59 Hematology Annual Meeting 59 Octreolin 59 JAK3 inhibitor 59 ALN PCS 59 CD# CEA 59 COMFORT II 59 Nasdaq RGEN 59 Sipuleucel T 59 CRMD# 59 mGluR5 negative 59 Phase 1b dose escalation 59 GW# [003] 59 PCI ExTRACT TIMI 59 Nasdaq ISTA 59 Corporation Nasdaq PHRM 59 Carotid Revascularization Endarterectomy vs. 59 BARACLUDE R 59 Tocosol Paclitaxel 59 Inc. Nasdaq MEDX 59 ENMD # 59 Zoraxel 59 Files IND 59 Chronic Hepatitis C